InnovVentures Partners

The firm's website lists no named principals, investment committee members, or deal-team professionals. Public record searches as of 2025 produce no individual names associated with investment decisions. This absence of disclosed leadership is unusual for a European private equity firm and may indicate a single-family-office-style decision architecture or a very small, closely held partnership not actively raising external capital.

The firm's stated focus on spin-offs suggests a sourcing model built on relationships with Swiss corporate development teams, particularly within Basel's pharmaceutical and industrial clusters. Spin-off transactions are inherently proprietary — they originate from internal corporate carve-out processes rather than broad auction processes. However, the firm has disclosed no completed deals to validate this sourcing thesis.

The firm's legal structure is not publicly disclosed. The absence of named professionals, fund documents, or LP communications is more consistent with a single-family-office or proprietary-capital vehicle than a conventional venture firm marketing to institutional investors. Altss classifies it as an asset manager based on the corporate website, but the operational reality may be closer to a private investment office.

The firm's stated strategy — buyout, early-stage venture, spin-offs, and startup creation — implies direct investing only. No language on the website references fund-of-funds commitments, LP positions in third-party funds, or co-investment club participation. This is a direct-deal shop by stated mandate.

The firm targets an unusually wide stage range. On the early side, it covers startup and early-stage venture investing. On the later side, it pursues buyout transactions. The spin-off strategy occupies a middle ground, often involving mature business units carved from larger corporates. This multi-stage mandate is operationally demanding and rare for a small firm.